Showing results (911-920 of 931) with videos related to

Sort By:
Pageof 94
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemiaSanne Lugthart, Stefan Gröschel, H Berna Beverloo, et al.
Influenza and Other Respiratory Viruses|February 24, 2023
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022Sara S Kim, Jessie R Chung, H Keipp Talbot, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2013
Application of receiver operating characteristic analysis to refine the prediction of potential digoxin drug interactionsHarma Ellens, Shibing Deng, Joann Coleman, et al.
Lancet (London, England)|October 25, 2017
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study GroupPeter Borchmann, Helen Goergen, Carsten Kobe, et al.
Blood|April 29, 2015
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IVSusanne Saussele, Marie-Paloma Krauss, Rüdiger Hehlmann, et al.
Nature Communications|May 26, 2026
An X-linked sex determination mechanism in cannabis and hopSarah B Carey, Philip C Bentz, John T Lovell, et al.
Blood|December 28, 2020
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trialSilke Kapp-Schwoerer, Daniela Weber, Andrea Corbacioglu, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
An X-linked sex determination mechanism in cannabis and hopSarah B Carey, Philip C Bentz, John T Lovell, et al.
The Journal of Clinical Investigation|November 3, 2022
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patientsSixten Körper, Beate Grüner, Daniel Zickler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 27, 2013
Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteriaJoe Bentz, Michael P O'Connor, Dallas Bednarczyk, et al.
Pageof 94